Buckland PR - Search Results

1

Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment.

Buckland PR, O'Donovan MC, McGuffin P. Buckland PR, et al. Psychopharmacology (Berl). 1992;108(1-2):98-102. doi: 10.1007/BF02245292. Psychopharmacology (Berl). 1992. PMID: 1357712

2

Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter.

Spurlock G, Buckland P, O'Donovan M, McGuffin P. Spurlock G, et al. Neuropharmacology. 1994 Mar-Apr;33(3-4):433-40. doi: 10.1016/0028-3908(94)90073-6. Neuropharmacology. 1994. PMID: 7984281

3

Bi-directional changes in the levels of messenger RNAs encoding gamma-aminobutyric acidA receptor alpha subunits after flurazepam treatment.

O'Donovan MC, Buckland PR, Spurlock G, McGuffin P. O'Donovan MC, et al. Among authors: buckland pr. Eur J Pharmacol. 1992 Aug 3;226(4):335-41. doi: 10.1016/0922-4106(92)90051-v. Eur J Pharmacol. 1992. PMID: 1327846

4

Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.

Buckland PR, O'Donovan MC, McGuffin P. Buckland PR, et al. Psychopharmacology (Berl). 1992;106(4):479-83. doi: 10.1007/BF02244818. Psychopharmacology (Berl). 1992. PMID: 1349752

5

Lack of effect of chronic antipsychotic treatment on dopamine D5 receptor mRNA level.

Buckland PR, O'Donovan MC, McGuffin P. Buckland PR, et al. Eur Neuropsychopharmacol. 1992 Dec;2(4):405-9. doi: 10.1016/0924-977x(92)90002-p. Eur Neuropsychopharmacol. 1992. PMID: 1362660

6

The effects of antidepressant drugs on kainate receptor mRNA levels.

Havard HL, Buckland PR, O'Donovan MC, McGuffin P. Havard HL, et al. Among authors: buckland pr. Neuropharmacology. 1991 Jun;30(6):675-7. doi: 10.1016/0028-3908(91)90090-x. Neuropharmacology. 1991. PMID: 1656306

7

Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains.

Oretti RG, Spurlock G, Buckland PR, McGuffin P. Oretti RG, et al. Among authors: buckland pr. Neurosci Lett. 1994 Aug 15;177(1-2):39-43. doi: 10.1016/0304-3940(94)90039-6. Neurosci Lett. 1994. PMID: 7824178

8

Clozapine and sulpiride up-regulate dopamine D3 receptor mRNA levels.

Buckland PR, O'Donovan MC, McGuffin P. Buckland PR, et al. Neuropharmacology. 1993 Sep;32(9):901-7. doi: 10.1016/0028-3908(93)90146-t. Neuropharmacology. 1993. PMID: 7901792

9

Both splicing variants of the dopamine D2 receptor mRNA are up-regulated by antipsychotic drugs.

Buckland PR, O'Donovan MC, McGuffin P. Buckland PR, et al. Neurosci Lett. 1993 Feb 5;150(1):25-8. doi: 10.1016/0304-3940(93)90099-7. Neurosci Lett. 1993. PMID: 8469398

10

Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels.

Buckland PR, Spurlock G, McGuffin P. Buckland PR, et al. Brain Res Mol Brain Res. 1996 Jan;35(1-2):69-76. doi: 10.1016/0169-328x(95)00182-r. Brain Res Mol Brain Res. 1996. PMID: 8717341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters